A RANDOMIZED, DOUBLE BLIND, PLACEBO-CONTROLLED, PARALLEL-GROUP, MULTICENTER, EVENT DRIVEN PHASE III STUDY TO INVESTIGATE THE SAFETY AND EFFICACY OF FINERENONE, IN ADDITION TO STANDARD OF CARE, ON THE REDUCTION OF CARDIOVASCULAR MORBIDITY AND MORTALITY
Principal Investigator(s)
Bansal,Shweta
Funded by
BAYER PHARMACEUTICAL
Research Start Date
Status
Active